Year archive

ARGENICA THERAPEUTICS LIMITED — 2026 filings

All 12 regulatory filings released by ARGENICA THERAPEUTICS LIMITED (AGN) in 2026, sourced directly from the official regulator.

12 Filings

2026 Period

2026 filings (12)

Filing	Released	Lang
Release of Securities from Voluntary Escrow 1 page 157.0KB Share Issue/Capital Change	2026-05-25	English
IND Application Advanced With Successful Completion of Assay 4 pages 343.8KB Regulatory Filings	2026-05-20	English
Clinical Advisory Committee Established to Advance Phase 2b 2 pages 256.9KB Regulatory Filings	2026-05-13	English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 479.8KB Interim / Quarterly Report Q3 2026	2026-04-28	English
Investor Presentation - Ignite Conference 14 pages 2.4MB Investor Presentation	2026-04-15	English
Presentations at European Stroke Organisation Conference 2 pages 308.3KB Regulatory Filings	2026-03-25	English
Argenica Receives $3.97m R&D Tax Incentive Cash Rebate 1 Regulatory Filings	2026-03-16	English
Half Yearly Report and Accounts 18 pages 1.1MB Interim / Quarterly Report H1 2026	2026-02-10	English
Investor Presentation - Euroz Hartleys Healthcare Conference 20 pages 2.8MB Investor Presentation	2026-02-04	English
Successful Applicaton for EMA Paediatric Waiver 3 pages 294.1KB Regulatory Filings	2026-02-01	English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 513.4KB Interim / Quarterly Report H1 2026	2026-01-27	English
Final Director's Interest Notice 2 pages 246.3KB Director's Dealing	2026-01-01	English